1 Dept of Pediatric Cardiac Surgery, The Children's Hospital, Boston, MA 02115
Therapeutic options for the treatment of patent ductus arteriosus (PDA) continue to evolve. Gross and Hubbard reported the first surgical interruption in 1939.1 Transcatheter occlusion was achieved by Portsmann et al in 1971,2 and indomethacin therapy for premature newborns was described in 1976.3 Although preliminary results have been reported for several transcatheter PDA devices, none currently have Food and Drug Administration approval. Transcatheter coils are being placed in many institutions,4 and some patients are awaiting the availability of transcatheter devices. In an effort to reduce surgical trauma, advanced endoscopic imaging technology has been adapted for use in pediatric cardiothoracic surgery, enabling an interruption of the PDA with a minimally invasive transthoracic technique.5
Submitted on February 3, 1994
This article has been cited by other articles:
![]() |
S. Q. Yu, Z. J. Cai, Y. G. Cheng, D. W. Duan, X. Z. Xu, W. S. Chen, and G. X. Zhou Video-Assisted Thoracoscopic Surgery for Congenital Heart Disease Asian Cardiovasc Thorac Ann, September 1, 2002; 10(3): 228 - 230. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Miyaji, R. L. Hannan, J. Ojito, J. M. Dygert, J. A. White, and R. P. Burke Video-assisted cardioscopy for intraventricular repair in congenital heart disease Ann. Thorac. Surg., September 1, 2000; 70(3): 730 - 737. [Abstract] [Full Text] [PDF] |
||||